Overview
Lecia Van Dam Sequist is an Oncologist practicing medicine in Boston, Massachusetts.
Dr. Van Dam Sequist is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).
Dr. Van Dam Sequist is board certified in Medical Oncology. Dr. Van Dam Sequist is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
75 Francis St, Boston, MA 02115
2014 Washington St, Newton, MA 02462
40 2nd Ave, Waltham, MA 02451
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.
Office
Edwin Choy is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choy is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Osteosarcoma. Dr. Choy is currently accepting new patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.
Frequently Asked Questions about Dr. Lecia V. Van Dam Sequist
How do I make an appointment with Dr. Lecia V. Van Dam Sequist?
You can book an appointment with Dr. Lecia V. Van Dam Sequist by calling their office at 617-724-0287. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Lecia V. Van Dam Sequist a top-rated expert for Squamous Cell Lung Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lecia V. Van Dam Sequist is classified as an Distinguished expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Lecia V. Van Dam Sequist specialize in?
While Dr. Lecia V. Van Dam Sequist is a Oncology, they have specific expertise in Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Lecia V. Van Dam Sequist accept my insurance?
Dr. Lecia V. Van Dam Sequist accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-724-0287 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Van Dam Sequist isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Van Dam Sequist isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Van Dam Sequist isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Van Dam Sequist isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Van Dam Sequist isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Van Dam Sequist isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Van Dam Sequist isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Van Dam Sequist isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Van Dam Sequist isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Lung NodulesDr. Van Dam Sequist isAdvanced. Learn about Lung Nodules.
- Experienced
- Familial Pancreatic CancerDr. Van Dam Sequist isExperienced. Learn about Familial Pancreatic Cancer.
- MesotheliomaDr. Van Dam Sequist isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Van Dam Sequist isExperienced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Van Dam Sequist isExperienced. Learn about Neuroendocrine Tumor.
- Pancreatic CancerDr. Van Dam Sequist isExperienced. Learn about Pancreatic Cancer.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)Dr. Van Dam Sequist isExperienced. Learn about Paroxysmal Nocturnal Hemoglobinuria (PNH).
- Posterior Fossa TumorDr. Van Dam Sequist isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Van Dam Sequist isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Undifferentiated Connective Tissue Disease (UCTD)Dr. Van Dam Sequist isExperienced. Learn about Undifferentiated Connective Tissue Disease (UCTD).